Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Guohai Biological Pharmaceutical is a China-based biopharmaceutical company specializing in the research, development, and production of marine-derived drugs and biological products. The company focuses on leveraging marine biological resources to develop innovative therapies for oncology, cardiovascular conditions, and infectious diseases. Its operations include a comprehensive range of activities from basic research and clinical development to large-scale GMP manufacturing. Qingdao Guohai is recognized for its integration of marine biotechnology with modern pharmaceutical standards to address unmet medical needs in the domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Guohai Biological Pharmaceutical.